460 articles in this topic
DuoStim lets women with poor ovarian reserve collect more eggs in one cycle, potentially cutting time to a successful pregnancy.
Spatial transcriptomics reveals how aging disrupts the cellular choreography of ovarian cycling, triggering inflammation and tissue disorganization early.
New research finds that serum FT3 may reveal inadequate thyroid hormone action even when TSH appears normal in post-thyroidectomy patients.
Single-nucleus RNA sequencing reveals TRT partially reverses fibrotic and inflammatory muscle changes in hypogonadal Klinefelter men.
Even after biochemical remission, Cushing patients with normalized nighttime cortisol show dramatically better mood, energy, and quality of life.
A JAMA viewpoint exposes how illicit injectable peptides are escaping regulation as the line between medicine and enhancement blurs.
GLP-1 receptor agonists used for weight loss may also restore male reproductive hormones and improve sperm parameters.
A Phase II crossover trial directly compares Chronocort and Plenadren to find the optimal hydrocortisone replacement for adrenal insufficiency.
A case-based clinical guide addresses gender-affirming hormone therapy alongside dementia, heart disease, prostate cancer, and bone loss in older TGD adults.
A third of focal congenital hyperinsulinism cases showed spontaneous glycemic improvement, raising questions about routine surgical intervention.
A novel saliva-based marker for dexamethasone absorption may enable at-home Cushing's screening, cutting clinic visits.
The largest-ever cohort study of Sanjad-Sakati syndrome reveals devastating multi-system disease burden and a median survival of just 27 years.
